CJC W/DAC 5mg

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH), and its primary function is to stimulate the release of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). The addition of Drug Affinity Complex (DAC) to CJC-1295 is aimed at extending its half-life in the bloodstream.

1. Synthetic Analogue of GHRH: CJC-1295 is designed to mimic the action of natural growth hormone-releasing hormone. By binding to and activating the GHRH receptor, it stimulates the release of growth hormone from the pituitary gland.
2. Increase in GH and IGF-1 Levels: CJC-1295 is known for its ability to elevate both growth hormone and insulin-like growth factor 1 levels in the blood. These hormones play essential roles in growth, metabolism, and various physiological functions.
3. DAC (Drug Affinity Complex): The addition of DAC to CJC-1295 is a modification intended to prolong its presence in the bloodstream. DAC increases the peptide’s stability and half-life, meaning that it remains active in the body for a more extended period compared to the non-modified form.
4. Extended Duration of Action: The presence of DAC allows for less frequent dosing of CJC-1295 while maintaining its effectiveness. This extended duration of action can be advantageous in therapeutic applications and may be preferred in certain contexts.